trending Market Intelligence /marketintelligence/en/news-insights/trending/qcig4rcdys06xtte7_qi4q2 content esgSubNav
In This List

TapImmune raises $3.1M via stock purchase agreement

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


TapImmune raises $3.1M via stock purchase agreement

TapImmune Inc. raised gross proceeds of about $3.1 million under a stock purchase agreement.

Under the agreement, an existing accredited investor bought 1,300,000 common shares at $2.40 each in a private placement.

Additionally, TapImmune raised gross proceeds of about $2 million under a warrant exercise agreement.

Under the agreement, certain existing institutional investors bought 782,506 shares at a reduced exercised price, and for cash immediately.

Jacksonville, Fla.-based TapImmune develops immunotherapeutics and vaccines for cancer and metastatic disease.